Publication | Closed Access

Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study

Surgical OncologyHepatologyMedicinePharmacologyConversion SurgerySurgeryPd-1 InhibitorLiver CancerCancer TreatmentOncologyReal-world Observational StudyHepatocellular Carcinoma